ACAD
32.3
-0.1
-0.31%
AEMD
4.86
+0.04
+0.83%
APRI
0.534
-0.008
-1.5498%
ARNA
1.72
-0.05
-2.82%
ATEC
0.221
-0.018
-7.4276%
CNAT
2.87
+0.02
+0.70%
CRXM
0.19
0.00
0.00%
CYTX
0.32
-0.02
-5.88%
DXCM
64.38
-1.58
-2.40%
GNMK
5.91
-0.16
-2.64%
HALO
10.55
-0.29
-2.68%
ILMN
134.99
-0.76
-0.56%
INNV
0.092
-0.004
-4.167%
INO
10.48
-0.7
-6.26%
ISCO
3.75
-0.1
-2.60%
ISIS
57.56
0.00
0.00%
LGND
120.87
-2.25
-1.83%
LPTN
0.233
-0.009
-3.6349%
MBVX
0.72
0.00
-0.66%
MEIP
1.4
0.00
0.00%
MNOV
6.88
-0.1
-1.43%
MRTX
20.72
-0.32
-1.52%
MSTX
0.295
-0.006
-1.8279%
NBIX
45.58
-1.32
-2.81%
NUVA
52.94
-0.16
-0.30%
ONCS
1.96
+0.01
+0.51%
ONVO
2.72
-0.03
-1.09%
OREX
0.447
-0.02
-4.201%
OTIC
14.26
-0.36
-2.46%
QDEL
17.3
-0.38
-2.15%
RCPT
231.96
0.00
0.00%
RGLS
5.84
-0.32
-5.19%
RMD
55.8
-0.7
-1.24%
SPHS
1.2
0.00
0.00%
SRNE
6.86
-0.04
-0.58%
TROV
4.02
-0.14
-3.37%
VICL
0.399
+0.004
+1.013%
VOLC
18
0.00
0.00%
ZGNX
10.25
-0.38
-3.57%
ACAD
32.3
-0.1
-0.31%
AEMD
4.86
+0.04
+0.83%
APRI
0.534
-0.008
-1.5498%
ARNA
1.72
-0.05
-2.82%
ATEC
0.221
-0.018
-7.4276%
CNAT
2.87
+0.02
+0.70%
CRXM
0.19
0.00
0.00%
CYTX
0.32
-0.02
-5.88%
DXCM
64.38
-1.58
-2.40%
GNMK
5.91
-0.16
-2.64%
HALO
10.55
-0.29
-2.68%
ILMN
134.99
-0.76
-0.56%
INNV
0.092
-0.004
-4.167%
INO
10.48
-0.7
-6.26%
ISCO
3.75
-0.1
-2.60%
ISIS
57.56
0.00
0.00%
LGND
120.87
-2.25
-1.83%
LPTN
0.233
-0.009
-3.6349%
MBVX
0.72
0.00
-0.66%
MEIP
1.4
0.00
0.00%
MNOV
6.88
-0.1
-1.43%
MRTX
20.72
-0.32
-1.52%
MSTX
0.295
-0.006
-1.8279%
NBIX
45.58
-1.32
-2.81%
NUVA
52.94
-0.16
-0.30%
ONCS
1.96
+0.01
+0.51%
ONVO
2.72
-0.03
-1.09%
OREX
0.447
-0.02
-4.201%
OTIC
14.26
-0.36
-2.46%
QDEL
17.3
-0.38
-2.15%
RCPT
231.96
0.00
0.00%
RGLS
5.84
-0.32
-5.19%
RMD
55.8
-0.7
-1.24%
SPHS
1.2
0.00
0.00%
SRNE
6.86
-0.04
-0.58%
TROV
4.02
-0.14
-3.37%
VICL
0.399
+0.004
+1.013%
VOLC
18
0.00
0.00%
ZGNX
10.25
-0.38
-3.57%
Home » Archive by Category

Drug Discovery

San Diego’s Antibody-Drug Conjugate Research Highlighted at #WorldADC Meeting in October

November 24, 2014 – 8:11 am
WorldADC

San Diego was host to the World Antibody Drug Conjugate (ADC) Meeting and Awards October 26-29th 2014. ADCs are an exciting new class of oncology therapeutics utilizing monoclonal antibodies conjugated to cytotoxic drugs, resulting in …

SDBN August 21st 2012 Event At The Sanford Consortium For Regenerative Medicine

August 3, 2012 – 12:41 pm

The Sanford Consortium for Regenerative Medicine is a stem cell research facility representing a collaboration between five of San Diego’s finest research institutions: Sanford-Burnham Medical Research Institute, The Salk Institute, The Scripps Research Institute and …

SDBN June 25th Event With Lilly: Open Innovation Drug Discovery

June 4, 2012 – 1:48 am

San Diego biotech has grown thanks to a collaborative spirit which is sometimes manifested in the acquisition and joining of companies towards a common goal. Lilly’s presence here is indicative of this type of growth, …

San Diego’s Biotechnology Companies: Who’s Taking Off?

March 8, 2012 – 9:13 am

Here at SDBN we’ve been updating our directory of 400+ San Diego biotech companies.  We were surprised to find close to 40 companies removed from the local scene – due to acquisition or shut down.  …

SDBN March 26th 2012 Event with Organovo

March 6, 2012 – 1:59 pm

Organovo is an exciting San Diego biotech company with technology to create human tissue through a technique called 3D bioprinting. The tissue can be used for drug discovery and development, and the company has been …

Focus on San Diego: Life Science Conferences Spring 2012

January 31, 2012 – 11:56 am

This spring San Diego downtown will be buzzing with scientific discussions as our city hosts a number of major scientific symposia.  We are excited to attend and soak in all the science that will be …

Virtual Biotech Part 1: What We Learned About Effectively Outsourcing a Drug Discovery Program

July 28, 2011 – 12:04 pm

The first in our Virtual Biotech series, our July 19th event was a success.  Thanks to our participants – some of San Diego’s leading virtual drug discovery scientists and CROs – for sharing their valuable …

SDBN July 19th Event: Virtual Biotech Part 1: How to Effectively Outsource a Drug Discovery Program

July 1, 2011 – 3:47 pm

Changes in the drug discovery landscape have presented many tough challenges for our region, including downsizing for larger companies and a dearth of VC funding for startups. With these challenges come opportunities, however, because drug …

SDBN June 21st Event Featuring aTyr Pharma

May 27, 2011 – 9:58 am

The San Diego Biotechnology Network’s June 21st event will feature aTyr Pharma, with Board Member and CEO Jeffry Watkins (Bio) giving a talk titled “Innovation: Where is our Biology?” aTyr is developing therapeutics based on …

SDBN April 19th 2011 Event Featuring Celgene

March 22, 2011 – 6:15 pm

Through research, acquisitions, and mergers, Celgene has built a robust product portfolio and pipeline in hematology and oncology. This accomplishment is quite a feat in today’s environment, with pharma pipelines dwindling, and they are one …